MedPath

In chronic urticaria patients Which drug is better between tab bilastine 20 mg and tab levocetirizine 10 mg

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: L509- Urticaria, unspecified
Registration Number
CTRI/2022/12/047982
Lead Sponsor
Dr Jaydev Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of acute & chronic urticaria aged between 18-75 years.

Patients who are willing to give written informed consent

Patients with minimum UAS of 5 or greater than it

Exclusion Criteria

Patients with : Urticarial vasculitis

Senile prutitus

Drug induced urticaria

Herediatary angioedema will be excluded

Patient taken antihistaminic in last 4 weeks

Patient taken corticosteroid in last 4 weeks

Patient having known hypersensitivity to the drug

Patients on immunosuppressive therapy ( cyclosporine, methotrexate, azathioprine)

Pregnant and lactating females

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.